Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Caveat emptor: editors beware.

× No keyword cloud information.

17 in total

1. The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.

Authors: Laura Orio; Sunmee Wee; Amy H Newman; Luigi Pulvirenti; George F Koob
Journal: Addict Biol Date: 2010-04-29 Impact factor: 4.280

2. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.

Authors: Maartje M L De Win; Gerry Jager; Hylke K E Vervaeke; Thelma Schilt; Liesbeth Reneman; Jan Booij; Frank C Verhulst; Gerard J Den Heeten; Nick F Ramsey; Dirk J Korf; Wim Van den Brink
Journal: Int J Methods Psychiatr Res Date: 2005 Impact factor: 4.035

3. MDMA: on the translation from rodent to human dosing.

Authors: A Richard Green; Johan Gabrielsson; Charles A Marsden; Kevin C F Fone
Journal: Psychopharmacology (Berl) Date: 2009-01-13 Impact factor: 4.530

4. Comment on the letter by Green, Gabrielsson, Marsden, and Fone, MDMA: on the translation from rodent to human dosing.

Authors: Rafael de la Torre; Elena Puerta; Norberto Aguirre
Journal: Psychopharmacology (Berl) Date: 2009-01-16 Impact factor: 4.530

5. MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate.

Authors: Courtney L Huff; Rachel L Morano; James P Herman; Bryan K Yamamoto; Gary A Gudelsky
Journal: Neurotoxicology Date: 2016-10-20 Impact factor: 4.294

Review 6. Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

Authors: Lee E Dunlap; Anne M Andrews; David E Olson
Journal: ACS Chem Neurosci Date: 2018-07-12 Impact factor: 4.418

Review 7. Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.

Authors: A R Green; M V King; S E Shortall; K C F Fone
Journal: Br J Pharmacol Date: 2012-07 Impact factor: 8.739

8. Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage.

Authors: Giulia Costa; Micaela Morelli; Nicola Simola
Journal: Neurotox Res Date: 2017-06-09 Impact factor: 3.911

9. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study.

Authors: Gerry Jager; Maartje M de Win; Hylke K Vervaeke; Thelma Schilt; Rene S Kahn; Wim van den Brink; Jan M van Ree; Nick F Ramsey
Journal: Psychopharmacology (Berl) Date: 2007-05-03 Impact factor: 4.530

10. Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems.

Authors: Stefan Braeuninger; Christoph Kleinschnitz
Journal: Exp Transl Stroke Med Date: 2009-11-25